Biomarkers of Neuromyelitis Optica Other than Aquaporin 4 Antibody

Suh, Bum Chun

J Mult Scler > Volume 2(2); 2011 > Article

Review Article

Journal of Multiple Sclerosis 2011;2(2):40-44.
Published online September 1, 2011.

Aquaporin 4 항체 이외의 시신경척수염 생물표지자

서범천

성균관대학교 의과대학 강북삼성병원 신경과

Biomarkers of Neuromyelitis Optica Other than Aquaporin 4 Antibody

Bum Chun Suh

Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

Abstract

"Neuromyelitis optica (NMO) is a central nervous system inflammatory disease with humoral autoimmune pathogenesis, characteristically involving optic nerve and spinal cord. Until the identification of NMO IgG/AQP4 Ab, there was some confusion about the nature of this disease, whether NMO is an extreme phenomenon of multiple sclerosis (MS) or NMO/MS is a different disease. Recently, NMO IgG/AQP4 Ab explains many aspects of NMO: different pathomechanism from MS, site and character of brain and spinal cord lesions, CSF elevation of astrocyte markers, aggravation of disease after IFN-β which is standard preventive treatment of MS, and therapeutic effect of B-cell targeted therapy. This review presents recent update of biomarkers other than NMO IgG/AQP4 such as BAFF (B-cell activating factor of the TNF family), IL-6, and astrocyte makers (GFAP, S100B), and it would be helpful to understand clinical usefulness of cerebrospinal fluid and serological markers associated with NMO. Journal of Multiple Sclerosis 2(2):40-44, 2011"

Key Words: Neuromyelitis optica, NMO IgG, Biomarker, BAFF, IL-6, GFAP